vs

Side-by-side financial comparison of Catalyst Bancorp, Inc. (CLST) and MILESTONE SCIENTIFIC INC. (MLSS). Click either name above to swap in a different company.

Catalyst Bancorp, Inc. is the larger business by last-quarter revenue ($2.7M vs $2.1M, roughly 1.3× MILESTONE SCIENTIFIC INC.). Catalyst Bancorp, Inc. runs the higher net margin — 17.2% vs -53.0%, a 70.2% gap on every dollar of revenue. On growth, MILESTONE SCIENTIFIC INC. posted the faster year-over-year revenue change (2.2% vs 1.4%). Over the past eight quarters, Catalyst Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs -4.3%).

Catalyst Bancorp, Inc. is a U.S.-based financial holding company that operates community banking subsidiaries. It provides a full range of retail and commercial banking products including checking and savings accounts, small business loans, residential mortgages, personal lending, and wealth management services, primarily serving local regional markets across the U.S. with a focus on individual consumers and small business clients.

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

CLST vs MLSS — Head-to-Head

Bigger by revenue
CLST
CLST
1.3× larger
CLST
$2.7M
$2.1M
MLSS
Growing faster (revenue YoY)
MLSS
MLSS
+0.8% gap
MLSS
2.2%
1.4%
CLST
Higher net margin
CLST
CLST
70.2% more per $
CLST
17.2%
-53.0%
MLSS
Faster 2-yr revenue CAGR
CLST
CLST
Annualised
CLST
12.6%
-4.3%
MLSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLST
CLST
MLSS
MLSS
Revenue
$2.7M
$2.1M
Net Profit
$456.0K
$-1.1M
Gross Margin
73.0%
Operating Margin
20.8%
-52.5%
Net Margin
17.2%
-53.0%
Revenue YoY
1.4%
2.2%
Net Profit YoY
-27.2%
46.4%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLST
CLST
MLSS
MLSS
Q4 25
$2.7M
$2.1M
Q3 25
$2.8M
$2.4M
Q2 25
$2.8M
$2.3M
Q1 25
$2.9M
$2.2M
Q4 24
$2.5M
$2.0M
Q3 24
$3.2M
$2.5M
Q2 24
$2.8M
$1.9M
Q1 24
$2.1M
$2.2M
Net Profit
CLST
CLST
MLSS
MLSS
Q4 25
$456.0K
$-1.1M
Q3 25
$489.0K
$-1.2M
Q2 25
$521.0K
$-1.5M
Q1 25
$586.0K
$-2.0M
Q4 24
$626.0K
$-2.0M
Q3 24
$447.0K
$-1.5M
Q2 24
$527.0K
$223.6K
Q1 24
$-4.7M
$-1.4M
Gross Margin
CLST
CLST
MLSS
MLSS
Q4 25
73.0%
Q3 25
69.5%
Q2 25
69.6%
Q1 25
73.8%
Q4 24
75.0%
Q3 24
73.0%
Q2 24
76.1%
Q1 24
74.5%
Operating Margin
CLST
CLST
MLSS
MLSS
Q4 25
20.8%
-52.5%
Q3 25
21.7%
-48.1%
Q2 25
22.5%
-63.9%
Q1 25
24.7%
-89.5%
Q4 24
31.2%
-101.4%
Q3 24
17.6%
-58.4%
Q2 24
23.0%
-96.0%
Q1 24
-284.6%
-65.1%
Net Margin
CLST
CLST
MLSS
MLSS
Q4 25
17.2%
-53.0%
Q3 25
17.7%
-48.9%
Q2 25
18.5%
-63.8%
Q1 25
20.1%
-89.3%
Q4 24
25.3%
-101.1%
Q3 24
14.2%
-58.1%
Q2 24
18.7%
12.1%
Q1 24
-224.0%
-64.1%
EPS (diluted)
CLST
CLST
MLSS
MLSS
Q4 25
$0.13
Q3 25
$0.13
$-0.01
Q2 25
$0.14
Q1 25
$0.16
Q4 24
$0.13
Q3 24
$0.11
$-0.02
Q2 24
$0.13
Q1 24
$-1.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLST
CLST
MLSS
MLSS
Cash + ST InvestmentsLiquidity on hand
$25.2M
$1.1M
Total DebtLower is stronger
$14.7M
Stockholders' EquityBook value
$81.7M
$2.8M
Total Assets
$282.9M
$7.8M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLST
CLST
MLSS
MLSS
Q4 25
$25.2M
$1.1M
Q3 25
$37.3M
$1.3M
Q2 25
$40.1M
$1.3M
Q1 25
$40.3M
$2.2M
Q4 24
$44.3M
$3.3M
Q3 24
$45.8M
$4.8M
Q2 24
$75.5M
$5.8M
Q1 24
$76.0M
$5.0M
Total Debt
CLST
CLST
MLSS
MLSS
Q4 25
$14.7M
Q3 25
$14.7M
Q2 25
Q1 25
Q4 24
$9.6M
Q3 24
$29.5M
Q2 24
$30.3M
Q1 24
$29.4M
Stockholders' Equity
CLST
CLST
MLSS
MLSS
Q4 25
$81.7M
$2.8M
Q3 25
$81.6M
$2.5M
Q2 25
$80.8M
$3.3M
Q1 25
$80.6M
$4.5M
Q4 24
$80.2M
$5.8M
Q3 24
$81.7M
$7.2M
Q2 24
$81.0M
$8.0M
Q1 24
$81.3M
$7.5M
Total Assets
CLST
CLST
MLSS
MLSS
Q4 25
$282.9M
$7.8M
Q3 25
$283.8M
$8.5M
Q2 25
$273.8M
$8.1M
Q1 25
$271.6M
$9.1M
Q4 24
$276.7M
$9.8M
Q3 24
$280.6M
$11.2M
Q2 24
$295.3M
$12.0M
Q1 24
$282.0M
$11.4M
Debt / Equity
CLST
CLST
MLSS
MLSS
Q4 25
0.18×
Q3 25
0.18×
Q2 25
Q1 25
Q4 24
0.12×
Q3 24
0.36×
Q2 24
0.37×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLST
CLST
MLSS
MLSS
Operating Cash FlowLast quarter
$3.3M
$-226.1K
Free Cash FlowOCF − Capex
$3.1M
FCF MarginFCF / Revenue
116.8%
Capex IntensityCapex / Revenue
7.1%
Cash ConversionOCF / Net Profit
7.21×
TTM Free Cash FlowTrailing 4 quarters
$5.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLST
CLST
MLSS
MLSS
Q4 25
$3.3M
$-226.1K
Q3 25
$912.0K
$81.8K
Q2 25
$1.2M
$-1.8M
Q1 25
$427.0K
$-1.0M
Q4 24
$3.2M
$-1.5M
Q3 24
$896.0K
$-973.9K
Q2 24
$1.4M
$783.7K
Q1 24
$247.0K
$-1.2M
Free Cash Flow
CLST
CLST
MLSS
MLSS
Q4 25
$3.1M
Q3 25
$827.0K
Q2 25
$1.1M
Q1 25
$361.0K
Q4 24
$2.7M
Q3 24
$771.0K
Q2 24
$1.2M
Q1 24
$223.0K
FCF Margin
CLST
CLST
MLSS
MLSS
Q4 25
116.8%
Q3 25
29.9%
Q2 25
39.7%
Q1 25
12.4%
Q4 24
110.9%
Q3 24
24.5%
Q2 24
41.5%
Q1 24
10.7%
Capex Intensity
CLST
CLST
MLSS
MLSS
Q4 25
7.1%
Q3 25
3.1%
Q2 25
1.2%
Q1 25
2.3%
Q4 24
17.4%
Q3 24
4.0%
Q2 24
8.0%
Q1 24
1.1%
Cash Conversion
CLST
CLST
MLSS
MLSS
Q4 25
7.21×
Q3 25
1.87×
Q2 25
2.21×
Q1 25
0.73×
Q4 24
5.07×
Q3 24
2.00×
Q2 24
2.64×
3.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons